Lagging Immune Response to Haemophilus influenzae Serotype b (Hib) Conjugate Vaccine after the Primary Vaccination with Hib of Infants in The Netherlands

Autor: Leo Schouls, Corrie Schot, Richarda M. de Voer, Fiona van der Klis, Mirjam Knol, Irina Tcherniaeva, Guy Berbers

Publikováno v: Vaccines, Vol 8, Iss 3, p 347 (2020)

In 1993, a Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in the Dutch national immunization program, resulting in a sharp decrease in invasive Hib disease. We used a population-based set of serum samples collected in The Ne

Externí odkaz: https://doaj.org/article/bac5f350ba1c4681a9e164c79a280c29

Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study

Autor: Camelia Savulescu, Pavla Krizova, Palle Valentiner-Branth, Shamez Ladhani, Hanna Rinta-Kokko, Corinne Levy, Jolita Mereckiene, Mirjam Knol, Brita A. Winje, Pilar Ciruela, Sara de Miguel, Marcela Guevara, Laura MacDonald, Jana Kozakova, Hans-Christian Slotved, Norman K. Fry, J. Pekka Nuorti, Kostas Danis, Mary Corcoran, Arie van der Ende, Didrik F. Vestrheim, Carmen Munoz-Almagro, Juan-Carlos Sanz, Jesus Castilla, Andrew Smith, Edoardo Colzani, Lucia Pastore Celentano, Germaine Hanquet

Publikováno v: Vaccine
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Vaccine, 40(29), 3963-3974. Elsevier BV

Background: Pneumococcal conjugate vaccines covering 10 (PCV10) and 13 (PCV13) serotypes have been introduced in the infant immunization schedule of most European countries in 2010-11. To provide additional real-life data, we measured the effectivene

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf7370d11347f8a97059bcb74e97532
http://hdl.handle.net/10029/626003

Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO):a randomised, non-inferiority trial

Autor: Henry J C de Vries, Myrthe de Laat, Vita W Jongen, Titia Heijman, Carolien M Wind, Anders Boyd, Jolinda de Korne-Elenbaas, Alje P van Dam, Maarten F Schim van der Loeff, Sylvia Bruisten, Elske Hoornenborg, Mirjam Knol, Ron A.A. Mathôt, Jan M. Prins

Publikováno v: NABOGO steering group 2022, ' Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO) : a randomised, non-inferiority trial ', The Lancet Infectious Diseases, vol. 22, no. 5, pp. 706-717 . https://doi.org/10.1016/S1473-3099(21)00625-3
The Lancet Infectious Diseases, 22(5), 706-717. Lancet Publishing Group

Background: Neisseria gonorrhoeae causes gonorrhoea, a common sexually transmitted infection. Emerging strains resistant to first-line ceftriaxone threaten N gonorrhoeae management. Hence, alternative treatments are needed. We aimed to evaluate the e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc716dffef1faaa568d0be0ce50abdce
https://research.vumc.nl/en/publications/bd2de6ea-c354-4e18-b2e6-60d4ea727f21